# Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma

> **NCT01131689** · PHASE1 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** sorafenib, TS-1

## Key facts

- **NCT ID:** NCT01131689
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-09
- **Final completion:** 2011-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01131689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01131689, "Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01131689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*